研究单位:[1]Beijing TongRen Hospital,Beijing,China,100730[2]Chengdu Rhodiola Bio-Pharmaceutical Co Ltd
研究目的:
The purpose of this study is to assess the safety and tolerability of ocular administration of Topical Interleukin-1-Receptor Antagonist in healthy volunteers. Additionally, the PK of Interleukin-1-Receptor Antagonist will be assessed.